I.D.Neuro SRL
I.D.Neuro reported total assets of 435,683 € at the end of the 2025 financial year (annual accounts filed with the NBB on 31 Aug 2026).
The score of I.D.Neuro shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +41 % Total assets +221 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
I.D.Neuro's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 32,753 € | ||||
| Equity | 153,744 € | ||||
| Cash | 41,407 € | ||||
| EBITDA | 78,462 € | ||||
| Total assets | 435,683 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 31 Aug 2026
- Year ended 31 Dec 2024filed on 31 Aug 2025
- Year ended 31 Dec 2023filed on 28 Aug 2024
- Year ended 31 Dec 2022filed on 02 Jun 2023
- Year ended 31 Dec 2021filed on 27 May 2022
I.D.Neuro's financial analysis
- Solvency35.3%sector median: 67.6%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of I.D.Neuro
I.D.Neuro's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0866.870.885
- VAT number
- BE0866870885
- Peppol
- Registered · 0208:0866870885 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 20 Aug 2004
- Registered office
- 1000 Brussels
- Latest accounts
- 2025 · filed on 31 Aug 2026
- Activity
- Medical specialists activities (NACE 86220)
I.D.Neuro (SRL) has been based in Brussels since 2004, active in: medical specialists activities. For 2025, it reports a net profit of 32,753 € and equity of 153,744 €; its revenue is not published. Its solvency stands at 35.3%, below the median of its sector (67.6%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to I.D.Neuro
Companies in the same business, of comparable size and area, outside its group.
- DR Jordaan Stoop Medical specialists activities Zoersel · balance sheet 435,580 €
- Professeur Galand Ophtalmologie Medical specialists activities Neupré · balance sheet 435,968 €
- LABA Medical specialists activities Ottignies-Louvain-la-Neuve · balance sheet 435,326 €
- Bora MD Medical specialists activities Brussels · balance sheet 436,235 €
- Dr. Geraldine Accou, Oftalmologe Medical specialists activities Ghent · balance sheet 436,388 €
- Cabinet de Gynécologie du Docteur Polet Medical specialists activities Marche-en-Famenne · balance sheet 436,670 €
- BF Resp Oncology Medical specialists activities Overijse · balance sheet 434,641 €
- Vdwmedskin Medical specialists activities Oud-Heverlee · balance sheet 434,591 €
Frequently asked questions about I.D.Neuro
What is the revenue of I.D.Neuro?
I.D.Neuro files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of I.D.Neuro?
In Belgium, the VAT number is the company number prefixed with BE: BE0866870885 for I.D.Neuro, if the company is VAT-registered. Its company number (CBE) is 0866.870.885.
Where is the registered office of I.D.Neuro?
According to the CBE register, the registered office of I.D.Neuro is in 1000 Brussels.
What is the equity of I.D.Neuro?
At the close of the 2025 financial year, the equity of I.D.Neuro amounts to 153,744 €, a solvency of 35.3% of total assets.
Who manages I.D.Neuro?
The register lists 1 active mandates at I.D.Neuro. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of I.D.Neuro
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →